{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:24:46Z","timestamp":1760646286399},"reference-count":13,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["transplantation-proceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.transproceed.2014.12.007","type":"journal-article","created":{"date-parts":[[2015,1,30]],"date-time":"2015-01-30T22:18:16Z","timestamp":1422656296000},"page":"45-49","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Polyclonal Versus Monoclonal Induction Therapy in a Calcineurin Inhibitor\u2013Free Immunosuppressive Therapy in Renal Transplantation: A Comparison of Efficacy and Costs"],"prefix":"10.1016","volume":"47","author":[{"given":"A.","family":"S\u00e1nchez-Escuredo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Alsina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Diekmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Revuelta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Esforzado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Ricart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Cofan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Campistol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Oppenheimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2014.12.007_bib1","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/TP.0b013e3182472898","article-title":"Influence of induction modality on the outcome of deceased donor kidney transplant recipients discharged on steroid-free maintenance immunosuppression","volume":"93","author":"Sureshkumar","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2014.12.007_bib2","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.intimp.2011.07.012","article-title":"Induction antibody therapy in renal transplantation using early steroid withdrawal: long-term results comparing anti-IL2 receptor and anti-thymocyte globulin","volume":"11","author":"Lib\u00f3rio","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.transproceed.2014.12.007_bib3","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa060068","article-title":"Rabbit antithymocyte globulin versus basiliximab in renal transplantation","volume":"355","author":"Brennan","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2014.12.007_bib4","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1093\/ndt\/gfp174","article-title":"The cost-effectiveness of induction immunosuppression in kidney transplantation","volume":"24","author":"Morton","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2014.12.007_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1432-2277.1997.tb00528.x","article-title":"Changing patterns in organ donation in Eurotransplant, 1990\u201394","volume":"10","author":"Cohen","year":"1997","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2014.12.007_bib6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1034\/j.1600-6143.2002.20804.x","article-title":"Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor","volume":"2","author":"Rosengard","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2014.12.007_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1681\/ASN.V101167","article-title":"Rethinking chronic allograft nephropathy: the concept of accelerated senescence","volume":"10","author":"Halloran","year":"1999","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2014.12.007_bib8","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1111\/ajt.12460","article-title":"Long-term belatacept exposure maintains efficacy and safety at 5 years: results from the long-term extension of the BENEFIT study","volume":"13","author":"Rostaing","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2014.12.007_bib9","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2014.12.007_bib10","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1097\/TP.0b013e3182708e30","article-title":"Influence of delayed graft function and acute rejection on outcomes after kidney transplantation from donors after cardiac death","volume":"94","author":"Nagaraja","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2014.12.007_bib11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/01.tp.0000269610.13590.52","article-title":"Sequential quadruple immunosuppression including sirolimus in extended criteria and nonheartbeating donor kidney transplantation","volume":"84","author":"Diekmann","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2014.12.007_bib12","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/j.1600-6143.2004.00627.x","article-title":"De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years","volume":"4","author":"Flechner","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2014.12.007_bib13","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1093\/ndt\/16.5.1028","article-title":"An economic and quality-of-life assessment of basiliximab vs antithymocyte globulin immunoprophylaxis in renal transplantation","volume":"16","author":"Polsky","year":"2001","journal-title":"Nephrol Dial Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134514013050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134514013050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T02:06:17Z","timestamp":1651111577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134514013050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0041134514013050"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2014.12.007","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polyclonal Versus Monoclonal Induction Therapy in a Calcineurin Inhibitor\u2013Free Immunosuppressive Therapy in Renal Transplantation: A Comparison of Efficacy and Costs","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2014.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}